Impact of westernization on fibroblast growth factor 23 levels among individuals of African ancestry

Nephrology Dialysis Transplantation

Volumn 30, Issue 4, 2015, Pages 630-635

  Eckberg, Karl ^a   Kramer, Holly ^a   Wolf, Myles ^b   Durazo Arvizu, Ramon ^a   Tayo, Bamidele ^a   Luke, Amy ^a   Cooper, Richard ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

African diaspora; FGF23; phosphorus excretion; potassium excretion; sodium excretion

Indexed keywords

CREATININE; FIBROBLAST GROWTH FACTOR 23; BIOLOGICAL MARKER; FIBROBLAST GROWTH FACTOR; PHOSPHATE;

ADULT; AFRICAN; ARTICLE; BODY MASS; CONTROLLED STUDY; CREATININE URINE LEVEL; FEMALE; HUMAN; MALE; PHOSPHATE EXCRETION; PHOSPHATE INTAKE; PHOSPHATE URINE LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RURAL AREA; SEX DIFFERENCE; URINALYSIS; WESTERN DIET; BLACK PERSON; BLOOD; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGY; ETHNOLOGY; FEEDING BEHAVIOR; NIGERIA; UNITED STATES; URINE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; BIOMARKERS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CREATININE; CROSS-SECTIONAL STUDIES; DIET, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEEDING BEHAVIOR; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; MALE; NIGERIA; PHOSPHATES; UNITED STATES; URINALYSIS;

EID: 84926645697     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu342     Document Type: Article

References (28)

1. Kalantar-Zadeh K, Gutekunst L, Mehrotra R et al. Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol 2010; 5: 519-530
2. Noori N, Sims JJ, Kopple JD et al. Organic and inorganic dietary phosphorus and its management in chronic kidney disease. Iran J Kidney Dis 2010; 4: 89-100
3. Houston J, Isakova T, Wolf M. Phosphate metabolism and fibroblast growth factor 23 in chronic kidney disease. In: Kopple JD, Massry SG, Kalantar-Zadeh K, eds. Nutritional Management of Renal Disease. London: Academic Press, 2013; 285-308
4. Sullivan CM, Leon JB, Sehgal AR. Phosphorus-containing food additives and the accuracy of nutrient databases: implications for renal patients. J Ren Nutr 2007; 17: 350-354
5. Bell RR, Draper HH, Tzeng DY et al. Physiological responses of human adults to foods containing phosphate additives. J Nutr 1977; 107: 42-50
6. Parker BD, Schurgers LJ, Brandenburg VM et al. The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study. Ann Intern Med 2010; 152: 640-648
7. Ky B, Shults J, Keane MG et al. FGF23 modifies the relationship between vitamin D and cardiac remodeling. Circ Heart Fail 2013; 6: 817-824
8. Faul C, Amaral AP, Oskouei B et al. FGF23 induces left ventricular hypertrophy. J Clin Invest 2011; 121: 4393-4408
9. Gutierrez OM,Wolf M, Taylor EN. Fibroblast growth factor 23, cardiovascular disease risk factors, and phosphorus intake in the health professionals follow-up study. Clin J Am Soc Nephrol 2011; 6: 2871-2878
10. Mendez MA, Wynter S,Wilks R et al. Under-and overreporting of energy is related to obesity, lifestyle factors and food group intakes in Jamaican adults. Public Health Nutr 2004; 7: 9-19
11. Janse H, van Gelderen HH, Ruys JH. Assessment of urinary phosphate excretion in normal and abnormal children. Arch Dis Child 1966; 41: 541-544
12. Tayo B, Luke A, McKenzie CA et al. Patterns of sodium and potassium excretion and blood pressure in the African Diaspora. J Hum Hypertens 2012; 26: 315-324
13. Moe SM, Zidehsarai MP, Chambers MA et al. Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease. Clin J Am Soc Nephrol 2011; 6: 257-264
14. Ferrari SL, Bonjour JP, Rizzoli R. Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. J Clin Endocrinol Metab 2005; 90: 1519-1524
15. Antoniucci DM, Yamashita T, Portale AA. Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. J Clin Endocrinol Metab 2006; 91: 3144-3149
16. Burnett SM, Gunawardene SC, Bringhurst FR et al. Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. J Bone Miner Res 2006; 21: 1187-1196
17. Gutierrez OM, Januzzi JL, Isakova T et al. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation 2009; 119: 2545-2552
18. Gutierrez OM, Mannstadt M, Isakova T et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 2008; 359: 584-592
19. Hsu HJ, Wu MS. Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients. Am J Med Sci 2009; 337: 116-122
20. Mirza MA, Larsson A, Lind L et al. Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community. Atherosclerosis 2009; 205: 385-390
21. Roos M, Lutz J, Salmhofer H et al. Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function. Clin Endocrinol (Oxf ) 2008; 68: 660-665
22. Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047
23. Ene-Obong HN, Enugu GI, Uwaegbute AC. Determinants of health and nutritional status of rural Nigerian women. J Health Popul Nutr 2001; 19: 320-330
24. Ma J, Johns RA, Stafford RS. Americans are not meeting current calcium recommendations. Am J Clin Nutr 2007; 85: 1361-1366
25. Durazo-Arvizu R, Camacho P, Bovet P et al. 25-Hydroxyvitamin D in Afro-origin populations at varying latitudes challenge the construct of a physiological norm. Am J Clin Nutr 2014; 100: 908-914
26. Takeda Y, Komaba H, Goto S et al. Effect of intravenous saccharated ferric oxide on serum FGF23 and mineral metabolism in hemodialysis patients. Am J Nephrol 2011; 33: 421-426
27. Braithwaite V, Jarjou LM, Goldberg GR et al. Iron status and fibroblast growth factor-23 in Gambian children. Bone 2012; 50: 1351-1356
28. Parra EJ, Marcini A, Akey J et al. Estimating African American admixture proportions by use of population-specific alleles. Am J Hum Genet 1998; 63: 1839-1851